PARIS AND SOUTH SAN FRANCISCO, California – (BUSINESS WIRE) – DNA Script, SAS, a leading pioneer in enabling DNA synthesis on demand, and baseclick GmbH today announced an exclusive licensing agreement that grants DNA Script the use of novel “Click” chemistry marketed by baseclick. In effect, this agreement allows DNA Script customers to enzymatically synthesize high purity nucleic acids with modifications using their SYNTAX ™ DNA printing system.
Click chemistry was originally developed by scientists at the Scripps Research Institute1 as a simple and easy way to chemically add modifications, such as dyes, to biomolecules. baseclick has expanded the use of Click …
Read More On Original Publisher
This Content is Original Published by @www.businesswire.com